Skip to content

CORTEX CPET System MetaLyzer3B

by Cortex Biophysik GmbH

CORTEX CPET System MetaLyzer3B is a Class II device made by Cortex Biophysik GmbH, cleared under FDA 510(k) K993641 on 14 Dec 2000 and listed in FDA GUDID since 24 Sep 2020 (UDI-DI 74250179233555), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K993641

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number74250179233555 UDI-DI Date24 Sep 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK993641 Date14 Dec 2000DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K993641 decided 14 Dec 2000 Active
  • FDA GUDID UDI-DI 74250179233555 listed 24 Sep 2020 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K993641
  2. Listed FDA GUDID 74250179233555

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
CORTEX CPET System
Generic name
Cardiopulmonary stress exercise monitoring system
Model / reference
MetaLyzer3B
Primary DI / UDI-DI
74250179233555
510(k) Number
FDA product code
BTY
GMDN term
Cardiopulmonary stress exercise monitoring system
Device class
Class II
Regulation number
868.1890
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code BTY (Calculator, Predicted Values, Pulmonary Function).

Other devices from Cortex Biophysik GmbH

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)